leadf
logo-loader
viewSativa Wellnesss Group Inc

Sativa Investments buys UK medicinal cannabis lab for £435K

“PhytoVista provides a UK-based laboratory facility available to all jurisdictions already testing CBD products commercially, and of course able to service the UK market if and when regulatory changes hit the UK too," said Sativa executive director Mark Blower

cannabis
Sativa says the purchase price was below the market value of assets and equipment

Sativa Investments PLC (AQSE:SATI) has agreed to buy PhytoVista Laboratories, a UK-based lab that tests cannabis oils and hemp products, for £435,000.

The British medicinal cannabis investment vehicle will pay £235,000 in cash and £200,000 worth of shares at 0.04p per share to buy PhytoVista from Carbon Managers Limited.

READ: Sativa Investments positions itself for 'huge opportunity' in medicinal cannabis

Carbon is wholly owned by Sativa’s chief executive Geremy Thomas but he was not involved in the decision-making for the deal.

Sativa independent directors Noel Lyons and Mark Blower assessed the deal and consulted Dr. Stuart Ungar, who is a member of the company's medicinal cannabis advisory board.

Sativa said the purchase price was well below the market value of the assets and equipment acquired. If purchased new, the equipment laboratory would cost more than £580,000, the company said.

“Every batch of medicinal cannabis including CBD oil requires stringent testing, including for cannabinoids, pesticides, heavy metals and mycotoxins, along with full testing for terpenes, residual solvents and microbiology,” Blower said.

“PhytoVista provides a UK-based laboratory facility available to all jurisdictions already testing CBD products commercially, and of course able to service the UK market if and when regulatory changes hit the UK too."

PhytoVista has preferred partner status to the UK's Cannabis Trades Association for batch testing of medicinal cannabis products.

Quick facts: Sativa Wellnesss Group Inc

Price: 2.35 GBX

AQSE:SATI
Market: AQSE
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Sativa Wellnesss Group Inc named herein, including the promotion by the Company of Sativa Wellnesss Group Inc in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Sativa Group PLC signs LOI with Stillcanna to become part of the company

  Sativa Group PLC (AQSE: SATI) CEO Henry Lees-Buckley joined Steve Darling from Proactive to discuss the company signing a letter of intent with Stillcanna for the companies to come together as one. Lees-Buckley discusses the reason behind this move and what it does for them in...

on 11/6/20

2 min read